Literature DB >> 1248653

Renal kallikrein: its localization and possible role in renal function.

O A Carretero, A G Scicli.   

Abstract

The distribution of kallikrein in dog kidneys was studied. It was found that kallikrein decreased from the outer to the inner cortex and that the medulla and papilla had very little kallikrein. The site of kallikrein secretion in the nephron was also studied by performing stop-flow techniques in dogs. The highest kallikrein concentration was found in the fractions with the lowest sodium concentration. It was concluded that kallikrein is secreted into the urine at the level of the distal tubule by either the tubule itself or by a structure related to this part of the nephron. In addition, the possible involvement of the kallikrein-kinin system in the regulation of sodium excretion was investigated. Circulating kinins and urinary kallikrein were increased in saline-loaded dogs. Urinary kallikrein also increased in dogs that have "escaped" the sodium-retaining effect of desoxycorticosterone. Experiments in rats with different sodium intake showed a relationship between water and sodium excretion and urinary kallikrein. These data suggest that the kallikrein-kinin system could participate in the regulation of the renal function at the level of the distal tubule or collecting duct.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1248653

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  8 in total

1.  Renal release of N-acetyl-seryl-aspartyl-lysyl-proline is part of an antifibrotic peptidergic system in the kidney.

Authors:  Cesar A Romero; Nitin Kumar; Pablo Nakagawa; Morel E Worou; Tang-Dong Liao; Edward L Peterson; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2018-11-07

2.  Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake.

Authors:  S B Levy; J J Lilley; R P Frigon; R A Stone
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

Review 3.  The kallikrein-kinin system in circulatory and metabolic homeostasis.

Authors:  R McConn; G L Haberland; J C Frölich
Journal:  World J Surg       Date:  1981-07       Impact factor: 3.352

4.  The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition.

Authors:  J M Vinci; J R Gill; R E Bowden; J J Pisano; J L Izzo; N Radfar; A A Taylor; R M Zusman; F C Bartter; H R Keiser
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

5.  Relationship between kallikrein and PRA after intravenous furosemide.

Authors:  G A Cinotti; G Stirati; F Taggi; R Ronci; B M Simonetti; A Pierucci
Journal:  J Endocrinol Invest       Date:  1979 Apr-Jun       Impact factor: 4.256

Review 6.  Salivary kallikrein excretion in hypertension.

Authors:  A Heidland; A Röckel; G Schmid
Journal:  Klin Wochenschr       Date:  1979-10-01

7.  Isolation of membrane-bound renal enzymes that metabolize kinins and angiotensins.

Authors:  P E Ward; E G Erdös; C D Gedney; R M Dowben; R C Reynolds
Journal:  Biochem J       Date:  1976-09-01       Impact factor: 3.857

8.  Direct action of rat urinary kallikrein on rat kidney to release renin.

Authors:  S Suzuki; R Franco-Saenz; S Y Tan; P J Mulrow
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.